The Covid pandemic drives Pfizer's 2022 revenue to a record $100 billion

[butterscotch]

Not a surprise but Pfizer recorded record profits in 2022 from its covid vaccine and anti-viral drug.

Pfizer sold $37.8 billion of its Covid vaccine last year, a small increase of 3% compared with 2021 as demand for the shots slowed.

Sales of Paxlovid, however, surged to $18.9 billion in 2022, which was the first full year the antiviral pill was available.

Pfizer expects its revenue to decline in 2023 by as much as 33% to a range of $67 billion to $71 billion as the world emerges from the pandemic and demand for its blockbuster Covid drugs slows.

The Covid pandemic drives Pfizer's 2022 revenue to a record $100 billion